Approved for: HIV-1 Treatment: In combination with other antiretroviral agents (e.g., Dolutegravir) for adults and pediatric patients. PrEP (Pre-Exposure Prophylaxis): To reduce the risk of sexually acquired HIV-1 infection in at-risk adults and adolescents.

Dosage and administration

Standard Dosage: One tablet taken orally once daily. ⚠️ Administration Guide: Take at the same time every day to maintain viral suppression or protection. Can be taken with or without food. For PrEP users: Adherence is crucial. Missing doses significantly increases the risk of HIV infection.

Unknown HIV Status (for PrEP): You must test negative for HIV immediately before starting PrEP. Taking this drug alone while HIV-positive can lead to drug resistance. Severe hepatic impairment. Hypersensitivity to Emtricitabine or Tenofovir.

Tafero EM is generally well-tolerated with fewer side effects than older TDF-based drugs: Mild nausea or headache. Renal & Bone Safety: Significantly lower risk of kidney toxicity and osteoporosis compared to Truvada/Tenvir-EM. Potential mild weight gain.

Tafero EM — Emtricitabine 200 mg + 25 mg, 30 pcs, Hetero

100% original product

Active ingredient

Emtricitabine Tenofovir Alafenamide

Manufacturer

Hetero

Dosage 200 mg + 25 mg

Dosage form Tablets

Tablets per pack 30

Tafero EM (Emtricitabine 200 mg / Tenofovir Alafenamide 25 mg)

Name: Tafero EM
Brand: Hetero
SKU: PROD-54
Price: 1758 UAH
Availability: InStock

1758₴ ~~1978₴~~ -11%

Tafero EM is a next-generation medication for HIV treatment and prevention (PrEP). Active ingredients: Emtricitabine (200 mg) + Tenofovir Alafenamide (25 mg).

Manufacturer: Hetero Healthcare (India). It is the generic equivalent of the advanced drug Descovy.

The Safety Revolution:

Unlike older drugs like Truvada (TDF), Tafero EM uses Tenofovir Alafenamide (TAF). This molecule targets cells more efficiently, allowing for a much lower dose (25 mg). The result is a highly effective drug with a superior safety profile for kidneys and bone density.

✅ Top Choice: Considered the modern gold standard for long-term therapy and prophylaxis.

Approved for:

HIV-1 Treatment: In combination with other antiretroviral agents (e.g., Dolutegravir) for adults and pediatric patients.
PrEP (Pre-Exposure Prophylaxis): To reduce the risk of sexually acquired HIV-1 infection in at-risk adults and adolescents.

Standard Dosage: One tablet taken orally once daily.

⚠️ Administration Guide:

Take at the same time every day to maintain viral suppression or protection.
Can be taken with or without food.
For PrEP users: Adherence is crucial. Missing doses significantly increases the risk of HIV infection.

Unknown HIV Status (for PrEP): You must test negative for HIV immediately before starting PrEP. Taking this drug alone while HIV-positive can lead to drug resistance.
Severe hepatic impairment.
Hypersensitivity to Emtricitabine or Tenofovir.

Tafero EM is generally well-tolerated with fewer side effects than older TDF-based drugs:

Mild nausea or headache.
Renal & Bone Safety: Significantly lower risk of kidney toxicity and osteoporosis compared to Truvada/Tenvir-EM.
Potential mild weight gain.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 12.03.2026